IRCT20200105046010N10招募中未知
In- Vivo Bioequivalence study of Aspirin tablets 81mg (Kharazmi Pharmaceuticals, Iran) with brand drug (ASPIRIN® 81mg Buyer, Germany) in Iranian healthy volunteers.
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •General health(liver, heart, kidney)
- •Body mass index(18-28)
- •Informed consent
- •Age(18-60)
排除标准
- •A history of cardiovascular disease
- •A history of liver & kidney disease
- •Alcohol & Drug addiction
- •Hypersensitivity to the drug
研究者
相似试验
招募中
不适用
In vivo Bioequivalence study of Aspirin tabletIRCT20220211053992N6Tabriz University of Medical Sciences24
招募中
Unknown
In vivo Bioequivalence study of Aspirin tabletIRCT20220211053992N20Tabriz University of Medical Sciences24
已完成
1 期
Pharmacokinetic study of aspirin powder and minitabletsJPRN-jRCTs031200140Hida Noriko6
招募中
不适用
In-vivo Bioequivalence Test of Abiraterone tablet 500 mg Actero Middle East with brand drug (ZYTIGA® 500 mg, Janssen Biotech, Germany)Bio equivalence test.IRCT20200105046010N57Actero middle east Pharm Co.24
招募中
不适用
In-vivo Bioequivalence Test of Abiraterone tablets with brand drug (ZYTIGA® 500 mg, Janssen Biotech, Germany)Bio equivalence test.IRCT20200105046010N55anoalvand Pharmaceutical Co24